July 4, 2024 - July 8, 2024
RHP
Ambey Laboratories IPO is a book built issue of Rs 44.68 crores. The issue is a combination of fresh issue of 62.58 lakh shares aggregating to Rs 42.55 crores and offer for sale of 3.12 lakh shares aggregating to Rs 2.12 crores.
Ambey Laboratories IPO opens for subscription on July 4, 2024 and closes on July 8, 2024. The allotment for the Ambey Laboratories IPO is expected to be finalized on Tuesday, July 9, 2024. Ambey Laboratories IPO will list on NSE SME with tentative listing date fixed as Thursday, July 11, 2024.
Ambey Laboratories IPO price band is set at ₹65 to ₹68 per share. The minimum lot size for an application is 2000 Shares. The minimum amount of investment required by retail investors is ₹136,000. The minimum lot size investment for HNI is 2 lots (4,000 shares) amounting to ₹272,000.
Fast Track Finsec Pvt Ltd is the book running lead manager of the Ambey Laboratories IPO, while Link Intime India Private Ltd is the registrar for the issue. The market maker for Ambey Laboratories IPO is Nikunj Stock Brokers.
Refer to Ambey Laboratories IPO RHP for detailed information.
Ambey Laboratories IPO Details
| IPO Date | July 4, 2024 to July 8, 2024 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Price Band | ₹65 to ₹68 per share |
| Lot Size | 2000 Shares |
| Total Issue Size | 6,570,000 shares (aggregating up to ₹44.68 Cr) |
| Fresh Issue | 6,258,000 shares (aggregating up to ₹42.55 Cr) |
| Offer for Sale | 312,000 shares of ₹10 (aggregating up to ₹2.12 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE SME |
| Share holding pre issue | 18,688,819 |
| Share holding post issue | 25,258,819 |
| Market Maker portion | 312,000 shares Nikunj Stock Brokers |
Ambey Laboratories IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50% of the Net Issue |
| Retail Shares Offered | Not less than 35% of the Net Issue |
| NII (HNI) Shares Offered | Not less than 15% of the Net Issue |
Ambey Laboratories IPO Timeline (Tentative Schedule)
Ambey Laboratories IPO opens on July 4, 2024, and closes on July 8, 2024.
| IPO Open Date | Thursday, July 4, 2024 |
| IPO Close Date | Monday, July 8, 2024 |
| Basis of Allotment | Tuesday, July 9, 2024 |
| Initiation of Refunds | Wednesday, July 10, 2024 |
| Credit of Shares to Demat | Wednesday, July 10, 2024 |
| Listing Date | Thursday, July 11, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on July 8, 2024 |
Ambey Laboratories IPO Lot Size
Investors can bid for a minimum of 2000 shares and in multiples thereof. Thebelow table depicts the minimum and maximum investment by retail investors and HNI in terms ofshares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 2000 | ₹136,000 |
| Retail (Max) | 1 | 2000 | ₹136,000 |
| HNI (Min) | 2 | 4,000 | ₹272,000 |
| Lot Size Calculator | |||
Ambey Laboratories IPO Promoter Holding
The promoters of the company are Archit Gupta, Arpit Gupta, Sarina Gupta and Rish*ta Gupta.
| Share Holding Pre Issue | 94.97% |
| Share Holding Post Issue |
About Ambey Laboratories Limited
Ambey Laboratories, incorporated in 1985, manufactures agrochemical products for crop protection. The company has been serving the agrochemical sector for almost four decades.
The company manufactures and supplies 2,4-D base chemicals.
The company's manufacturing facility in Behror, Rajasthan, is certified with ISO 9001:2015 by the Quality Research Organization and ISO 14001:2015 by the United Accreditation Foundation.
The company currently produces the following products for its customer base, which includes large corporates like Aromatic Rasayan Private Limited, JR Jindal Infraprojects Private Limited, and SC Formulator Co. Ltd:
- 2,4-D Acid 98% TC
- 2,4-D Sodium 95% SP
- 2,4-D Amine 866 | 720 | 480g/l SL
- 2,4-D Ethyl Hexyl Ester 96% TC
- 2,4-D Ethyl Ester 96% TC
- Chlorpyriphos 97%TC / 20%EC / 50%EC
- Thiamethoxam 96%TC / 25%WG / 75%SG
- Pretilachlor 95%TC / 50%EC / 37%EW
- Metribuzin 97%TC / 70%WS
- Hexaconazole 92%TC / 5%SC / 5%EC / 10%EC
- Metalaxyl 98%TC / 35%WS
As of October 31, 2023 the company employs 220 people in various departments.
Ambey Laboratories Limited Financial Information (Restated)
| Period Ended | 31 Jan 2024 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
| Assets | 8,620.84 | 5,761.85 | 5,592.94 | 4,461.80 |
| Revenue | 10,043.69 | 10,743.47 | 8,511.19 | 8,241.54 |
| Profit After Tax | 607.73 | 456.93 | 357.47 | 1,033.67 |
| Net Worth | 3,431.34 | 2,363.60 | 1,906.67 | -786.39 |
| Reserves and Surplus | 1,562.46 | 588.66 | 131.73 | -1,275.74 |
| Total Borrowing | 2,005.44 | 1,365.22 | 1,804.86 | 3,292.98 |
| Amount in ₹ Lakhs | ||||
Key Performance Indicator
The market capitalization of Ambey Laboratories IPO is Rs 171.64 Cr.
KPI as of January 31, 2024.
| KPI | Values |
|---|---|
| ROE | 20.80% |
| ROCE | 13.14% |
| Debt/Equity | 0.58 |
| RoNW | 20.80% |
| P/BV | 3.58 |
| PAT Margin (%) | 6.01 |
Check Ambey Laboratories IPO Peer Comparison here.
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 2.44 | 2.89 |
| P/E (x) | 27.81 | 23.54 |
Note:
- The Pre IPO EPS is calculated based on Pre issue shareholding as on date of RHP and the latestFY earnings as of March 31, 2023 that is available in RHP.
- The Post Issue EPS is calculated based on the Post issue shareholding and annualized FYearnings of January 31, 2024 that is available in RHP.
Objects of the Issue (Ambey Laboratories IPO Objectives)
The company intends to utilize the Net Proceeds for the following objects:
- To meet Working Capital Requirements
- General corporate purposes
- Issue related expenses
Ambey Laboratories IPO Review (Avoid)
[Dilip Davda] The company is operating in a highly competitive and fragmented segment of agrochemicals. It has posted inconsistency in its bottom lines for the reported periods. There is some garble in the offer documents on financial data. Based on FY24 annualized super earnings, the issue appears aggressively priced discounting all near term positives. There is no harm in skipping this “High Risk/Low Return” bet. Read detail review...
Ambey Laboratories IPO Prospectus
Ambey Laboratories IPO Rating
0.0
Rating:
Vote Here ...
- 1
- 2
- 3
- 4
- 5
Ambey Laboratories Limited Contact Details
Ambey Laboratories Limited
Ground Floor, Property No.555 Tarla Mohalla,
Ghitorni, West Delhi
New Delhi, -110030
Phone: 0124-4000788
Email: cs@ambeylab.com
Website: http://www.ambeylab.com/
Ambey Laboratories IPO Registrar
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: ambeylab.ipo@Linkintime.co.in
Website: https://linkintime.co.in/initial_offer/public-issues.html
Ambey Laboratories IPO - Buy or Not
Ambey Laboratories IPO Recommendation Summary
| Review By | Subscribe | Neutral | Avoid |
|---|---|---|---|
| Brokers | 0 | 0 | 1 |
| Members | 0 | 0 | 0 |
Read All ReviewsPost Your Review Manage Reviews
Ambey Laboratories IPO Lead Manager(s)
- Fast Track Finsec Pvt Ltd (Past IPO Performance)
Lead Manager Reports
- IPO Lead Manager Performance Summary
- IPO Lead Manager PerformanceTracker
SME IPO Enquiry
SME Company Owners
We could help you get listed on the stock market.
Contact us Today
Check our SME IPO Guide 
Ambey Laboratories IPO FAQs
Ambey Laboratories IPO is a SME IPO of 6,570,000 equity shares of the face value of ₹10 aggregating up to ₹44.68 Crores. The issue is priced at ₹65 to ₹68 per share. The minimum order quantity is 2000 Shares.
The IPO opens on July 4, 2024, and closes on July 8, 2024.
Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in Ambey Laboratories IPO using UPI as a payment gateway. Zerodha customers can apply in Ambey Laboratories IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Ambey Laboratories IPO through Zerodha
- Visit the Zerodha website and login to Console.
- Go to Portfolio and click the IPOs link.
- Go to the 'Ambey Laboratories IPO' row and click the 'Bid' button.
- Enter your UPI ID, Quantity, and Price.
- ‘Submit’ IPO application form.
- Visit the UPI App (net banking or BHIM) to approve the mandate.
Visit Zerodha IPO Application Process Review for more detail.
The Ambey Laboratories IPO opens on July 4, 2024 and closes on July 8, 2024.
Ambey Laboratories IPO lot size is 2000 Shares, and the minimum amount required is ₹136,000.
You can apply in Ambey Laboratories IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Ambey Laboratories IPO will be done on Tuesday, July 9, 2024, and the allotted shares will be credited to your demat account by Wednesday, July 10, 2024. Check the Ambey Laboratories IPO allotment status.
The Ambey Laboratories IPO listing date is not yet announced. The tentative date of Ambey Laboratories IPO listing is Thursday, July 11, 2024.
Ambey Laboratories IPO Message Board
Ranked Members | Members with Most Likes
Check Messages by Ranked Members
Find Ambey Laboratories IPO Latest Update
- Ambey Laboratories IPO Review
- Ambey Laboratories IPO Live Subscription
- Ambey Laboratories IPO Live News
- Ambey Laboratories IPO Allotment Status
- Ambey Laboratories IPO Basis of Allotment Document
- Ambey Laboratories IPO FAQs
Useful Articles
- Top 10 Discount Brokers | Top 10 Full-Service Brokers
- HUF Account Basics Explained (Bank, Demat and TradingAccount)
- List of All Articles...
Compare IPOs with Ambey Laboratories IPO
- Nephro Care India IPO vs Ambey Laboratories IPO
- Diensten Tech IPO vs Ambey Laboratories IPO
- Visaman Global Sales IPO vs Ambey Laboratories IPO
- Mason Infratech IPO vs Ambey Laboratories IPO
- Petro Carbon and Chemicals IPO vs Ambey Laboratories IPO
By Popular Stock Brokers
Kotak Securities
(Trade Free Plan)
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
